Area of research
Radiology, Nuclear Medicine and Imaging · Oncology
Research interest
Research interests include Chemistry, Cancer research, Medicine, Fibroblast activation protein, alpha, and In vivo.
First-in-human study of an optimized, potential kit-type, SSTR antagonist <sup>68</sup>Ga-DATA<sup>5m</sup>-LM4 in patients with metastatic neuroendocrine tumors
Radiomolecular Theranostics With Fibroblast-Activation-Protein Inhibitors and Peptides
Alpha-peptide receptor radionuclide therapy using actinium-225 labeled somatostatin receptor agonists and antagonists
From Automated Synthesis to In Vivo Application in Multiple Types of Cancer—Clinical Results with [68Ga]Ga-DATA5m.SA.FAPi
[68Ga]Ga-DATA5m-LM4, a PET Radiotracer in the Diagnosis of SST2R-Positive Tumors: Preclinical and First Clinical Results
Squaric Acid-Based Radiopharmaceuticals for Tumor Imaging and Therapy
Hybrid Chelator-Based PSMA Radiopharmaceuticals: Translational Approach
Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA5m chelators
Synthesis and labeling of a squaric acid containing PSMA-inhibitor coupled to AAZTA5 for versatile labeling with 44Sc, 64Cu, 68Ga and 177Lu
How deprotonation changes molecular self-assembly – an AFM study in liquid environment